Blooming Health is powering healthy aging in place by building a single touchpoint for improving connections between community-based aging services, older adults, and family caregivers. I lead our overall commercial strategy, growth, and customer partnerships. We are actively looking to partner with aging service providers and health plans to help drive improved client engagement and access to aging-in-place support services. Please reach out at kavitha@gobloominghealth.com

Women Business Leaders of the U.S. Health Care Industry Foundation (WBL) is a nonprofit organization housing the premier network of women executives across the health care industry. WBL’s mission is to connect and convene senior executive women in health care to create meaningful cross-sector relationships, advance their careers, and harness their collective power to improve the industry.

I developed and led the evidence generation plan for Noona in the context of obtaining reimbursement from payers in the US and Europe.

Noona is Varian’s patient engagement platform, which helps cancer patients get better access to care via its smart cloud-based mobile service for oncology care navigation. Noona is designed to capture patient-reported outcomes and connects patients with their cancer clinics in a proactive way to improve survival and save clinical resources. http://www.noona.com/I enabled partnerships with Pharma / Life science partners around using the Noona platform to improve real-world outcomes for patients on novel treatments through proactive symptom monitoring and intervention.

As a healthcare strategist driven to enable quality health for all, I supported organizations that improve health outcomes through upstream (disease prevention) and downstream interventions (disease treatment). Particularly, I advised and supported organizations by: - Enabling community-based organizations to successfully link their social services mission to health outcomes in the context of DSRIP or integrated care partnerships- Supporting a start-up in the development of a health technology that addresses social determinants of health (SDOH) - Informing successful use of real-world evidence (RWE) for patient-centered drug development (regulatory and reimbursement) - Developing funding strategies for efficient translation of early-stage life science technologies from bench to bedside

- Developed growth-focused commercial strategies to support 30+ healthcare clients in market entry, product development / launch/ market access, regulatory strategy, business development, and policy advocacy- Led case teams of 3-4 consultants, driving analytical work streams and synthesizing findings- Owned the client delivery process, managed project progress, and streamlined team communication- Contributed to project sales by supporting the biopharma business development team in sales meetings, writing proposals, and crafting sales & marketing materials - Worked across healthcare industry segments from pharma, biotech, diagnostics, medical devices, to digital health

- Conducted in-depth primary and secondary research to evaluate commercial opportunities across drugs, diagnostics, medical devices, and digital health- Advanced analytic capabilities in Excel, including model building for market / financial projections- Worked across multiple therapeutic areas including oncology, autoimmune, liver diseases (NASH), CNS / neurodegeneration and ophthalmology

Developed commercialization strategies and consulted on business development activities for Cytodel, an early stage life science startup in the CNS space

- Awarded the American Heart Association Postdoctoral Fellowship ($92,300 for 2 years awarded to top 4% among ~200 applicants)- Patented the molecular model of multiple domains in a kinase drug target called JAK2 to enable cancer drug design- Collaborated with computational experts to complement biochemical studies with molecular dynamics simulations

Developed the business plan for a therapeutic technology discovered at NYU

Organized career development events and led case studies on healthcare technologies / companies to expose young scientists to technology commercialization

Determined the molecular basis for oncogenic mutations in Jak2 using biochemical and computational approaches

- Designed an interdisciplinary syllabus and taught cancer biology to 20 high school students in a 3D virtual environment called Second Life- Collaborated with a Digital Arts graduate student to train the students in virtual reality

Purified recombinant SH3 domain of PI3 kinase and conducted protein folding studies using fluorescence spectroscopy

- Selected for the Visiting Students Research Program (VSRP) Fellowship (top 2% among ~1000 nationwide applicants)- Determined the impact of microenvironment changes on protein dynamics using light scattering and laser spectroscopy